Trials / Completed
CompletedNCT01272986
Trial of Screening for ALOA-IgG AtheroAbzyme Test
Trial of Screening for ALOA-IgG AtheroAbzyme Test Comparing Healthy,Asymptomatic Myocardial Ischemic and Acute Coronary Syndrome Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Omicron Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a trial of screening for ALOA-IgG AtheroAbzyme Test comparing healthy, asymptomatic myocardial ischemic and acute coronary syndrome patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ALOA IgG-Elisa | measurement of IgG Level in blood |
| DEVICE | ALOA IgG-AtheroAbzyme | measurement of IgG in blood |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-01-10
- Last updated
- 2011-03-08
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT01272986. Inclusion in this directory is not an endorsement.